LataMed AI Corp. (OTC: LMED), a development-stage digital health and artificial intelligence technology company, announced today that it has initiated an operational, technical, and commercial evaluation to potentially integrate installment-based healthcare payment capabilities through Cashea, one of Venezuela's leading buy-now-pay-later fintech platforms. The proposed initiative aims to reduce upfront financial barriers for patients seeking private healthcare services, including consultations, diagnostics, wellness programs, and other eligible offerings within the LataMed AI ecosystem.
Management believes that improving payment accessibility could support greater patient engagement, increased healthcare utilization, stronger platform adoption, and broader access to private healthcare services. By addressing affordability challenges, the company aims to strengthen its position as a technology-enabled healthcare marketplace serving patients, providers, and healthcare partners throughout Latin America. The potential integration aligns with LataMed AI's broader strategy of combining artificial intelligence, telehealth infrastructure, care coordination tools, and digital payment accessibility to create a more scalable healthcare marketplace.
Dr. Kevin Rodan Levy, Chief Executive Officer of LataMed AI Corp., stated: "We believe financial accessibility is a critical component of healthcare delivery. Our objective is to evaluate solutions that may help patients obtain timely medical care while simultaneously expanding the reach and utility of our healthcare ecosystem. We believe initiatives such as this have the potential to strengthen patient acquisition, improve engagement, and support long-term platform growth."
The company has not entered into a definitive commercial agreement related to this initiative as of the date of this release. Completion of any integration remains subject to further commercial discussions, technical implementation requirements, regulatory review, and customary business conditions. LataMed AI intends to provide additional updates as material developments occur. For additional information, visit https://latamed.ai or review the company's filings with the U.S. Securities and Exchange Commission at www.sec.gov.
LataMed AI Corp. is a development-stage digital health and AI technology company focused on building telehealth infrastructure, healthcare coordination tools, analytics capabilities, and AI-enabled solutions for emerging markets. The company's strategy is centered on developing technology platforms designed to support healthcare access, patient engagement, provider coordination, emergency medical response, pharmacy integration, and data-driven healthcare operations, with an initial regional focus on Latin America.
